Eli Lilly Stock Jumps on Obesity Drug's FDA Approval
The Eli Lilly drug, which will be marketed as an obesity treatment under the name Zepbound, is already sold as a diabetes treatment named Mounjaro.
Source: marketwatch.com
Page 23 - Andrew Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Andrew Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Andrew Baum Today - Breaking & Trending Today
Pfizer (PFE) Q3 2023 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2023.
Source: fool.com
Merck (MRK) Q3 2023 Earnings Call Transcript
MRK earnings call for the period ending September 30, 2023.
Source: fool.com
Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2023.
Source: fool.com
Novartis AG (NYSE:NVS) Q3 2023 Earnings Call Transcript
Operator: Good morning, and good afternoon, and welcome to the Novartis Q3 2023 Results Release Conference Call and Live Webcast.
Source: insidermonkey.com